AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 1-25/51
ADMINISTRATION OF NEOMYCIN RESISTANCE GENE MARKED EBV SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO PATIENTS WITH RELAPSED EBV-POSITIVE HODGKIN-DISEASE
Authors: ROSKROW MA ROONEY CM HESLOP HE BRENNER MK KRANCE RA GRESIK MV MCCLAIN K AGUILAR LK GRILLEY B ROB E CARRUM G
Citation: Ma. Roskrow et al., ADMINISTRATION OF NEOMYCIN RESISTANCE GENE MARKED EBV SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO PATIENTS WITH RELAPSED EBV-POSITIVE HODGKIN-DISEASE, Human gene therapy, 9(8), 1998, pp. 1237-1250
INFUSION OF CYTOTOXIC T-CELLS FOR THE PREVENTION AND TREATMENT OF EPSTEIN-BARR VIRUS-INDUCED LYMPHOMA IN ALLOGENEIC TRANSPLANT RECIPIENTS
Authors: ROONEY CM SMITH CA NG CYC LOFTIN SK SIXBEY JW GAN YJ SRIVASTAVA DK BOWMAN LC KRANCE RA BRENNER MK HESLOP HE
Citation: Cm. Rooney et al., INFUSION OF CYTOTOXIC T-CELLS FOR THE PREVENTION AND TREATMENT OF EPSTEIN-BARR VIRUS-INDUCED LYMPHOMA IN ALLOGENEIC TRANSPLANT RECIPIENTS, Blood, 92(5), 1998, pp. 1549-1555
IMPACT OF MANAGED CARE DECISIONS ON CANCER CARE
Authors: KRANCE RA
Citation: Ra. Krance, IMPACT OF MANAGED CARE DECISIONS ON CANCER CARE, Cancer practice, 5(6), 1997, pp. 339-341
MYELODYSPLASTIC SYNDROME IN CHILDREN - DIFFERENTIATION FROM ACUTE MYELOID-LEUKEMIA WITH A LOW BLAST COUNT
Authors: CHAN GCF WANG WC RAIMONDI SC BEHM FG KRANCE RA CHEN G FREIBERG A INGRAM I BUTLER D HEAD DR
Citation: Gcf. Chan et al., MYELODYSPLASTIC SYNDROME IN CHILDREN - DIFFERENTIATION FROM ACUTE MYELOID-LEUKEMIA WITH A LOW BLAST COUNT, Leukemia, 11(2), 1997, pp. 206-211
OUTCOMES OF TRANSPLANTATION WITH MATCHED-SIBLING AND UNRELATED-DONOR BONE-MARROW IN CHILDREN WITH LEUKEMIA
Authors: HONGENG S KRANCE RA BOWMAN LC SRIVASTAVA DK CUNNINGHAM JM HORWITZ EM BRENNER MK HESLOP HE
Citation: S. Hongeng et al., OUTCOMES OF TRANSPLANTATION WITH MATCHED-SIBLING AND UNRELATED-DONOR BONE-MARROW IN CHILDREN WITH LEUKEMIA, Lancet, 350(9080), 1997, pp. 767-771
HEPATIC ARTERIAL RESISTANCE INDEX - AN INDICATOR OF DIFFUSE LIVER-DISEASE IN CHILDREN TREATED WITH BONE-MARROW TRANSPLANTATION
Authors: KAUFFMAN WM HESLOP HE GRONEMEYER SA CHEN G KRANCE RA
Citation: Wm. Kauffman et al., HEPATIC ARTERIAL RESISTANCE INDEX - AN INDICATOR OF DIFFUSE LIVER-DISEASE IN CHILDREN TREATED WITH BONE-MARROW TRANSPLANTATION, Clinical Radiology, 52(12), 1997, pp. 903-906
COMPARISON OF OUTCOME OF ALLOGENEIC TRANSPLANTATION IN CHILDREN WITH LEUKEMIA USING UNRELATED DONORS OR MISMATCHED FAMILY MEMBER DONORS
Authors: BENAIM E KRANCE RA RICHARDSON S BOWMAN LC SRIVASTAVA DK CUNNINGHAM JM HORWITZ EM BRENNER MK HESLOP HE
Citation: E. Benaim et al., COMPARISON OF OUTCOME OF ALLOGENEIC TRANSPLANTATION IN CHILDREN WITH LEUKEMIA USING UNRELATED DONORS OR MISMATCHED FAMILY MEMBER DONORS, Blood, 90(10), 1997, pp. 466-466
LONG-TERM TRANSGENE EXPRESSION BY HUMAN HEMATOPOIETIC-CELLS IN-VIVO
Authors: RILL DR HOLLIDAY M HESLOP HE KRANCE RA KIMBROUGH S KLINGEMANN H BRENNER MK
Citation: Dr. Rill et al., LONG-TERM TRANSGENE EXPRESSION BY HUMAN HEMATOPOIETIC-CELLS IN-VIVO, Blood, 90(10), 1997, pp. 1799-1799
LONG-TERM RESTORATION OF IMMUNITY AGAINST EPSTEIN-BARR-VIRUS INFECTION BY ADOPTIVE TRANSFER OF GENE-MODIFIED VIRUS-SPECIFIC T-LYMPHOCYTES
Authors: HESLOP HE NG CYC LI CF SMITH CA LOFTIN SK KRANCE RA BRENNER MK ROONEY CM
Citation: He. Heslop et al., LONG-TERM RESTORATION OF IMMUNITY AGAINST EPSTEIN-BARR-VIRUS INFECTION BY ADOPTIVE TRANSFER OF GENE-MODIFIED VIRUS-SPECIFIC T-LYMPHOCYTES, Nature medicine, 2(5), 1996, pp. 551-555
USE OF DOUBLE MARKING WITH RETROVIRAL VECTORS TO DETERMINE RATE OF RECONSTITUTION OF UNTREATED AND CYTOKINE EXPANDED CD34(-CELLS IN PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION() SELECTED MARROW)
Authors: HESLOP HE BRENNER MK KRANCE RA BOWMAN L CUNNINGHAM JM RICHARDSON S ALEXANDER B HEIDEMAN R BOYETT JM MARCUS SG BERENSON R HEIMFELD S BROWN S
Citation: He. Heslop et al., USE OF DOUBLE MARKING WITH RETROVIRAL VECTORS TO DETERMINE RATE OF RECONSTITUTION OF UNTREATED AND CYTOKINE EXPANDED CD34(-CELLS IN PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION() SELECTED MARROW), Human gene therapy, 7(5), 1996, pp. 655-667
MOLECULAR ANALYSIS OF THE PML RAR-ALPHA CHIMERIC GENE IN PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA/
Authors: KANE JR HEAD DR BALAZS L HULSHOF MG MOTRONI TA RAIMONDI SC CARROLL AJ BEH FG KRANCE RA SHURTLEFF SA DOWNING JR
Citation: Jr. Kane et al., MOLECULAR ANALYSIS OF THE PML RAR-ALPHA CHIMERIC GENE IN PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA/, Leukemia, 10(8), 1996, pp. 1296-1302
USE OF GENE MARKING IN BONE-MARROW TRANSPLANTATION
Authors: HESLOP HE ROONEY CM RILL DR KRANCE RA BRENNER MK
Citation: He. Heslop et al., USE OF GENE MARKING IN BONE-MARROW TRANSPLANTATION, Cancer detection and prevention, 20(2), 1996, pp. 108-113
GAMMA-DELTA T-LYMPHOCYTE REGENERATION AFTER T-LYMPHOCYTE-DEPLETED BONE-MARROW TRANSPLANTATION FROM MISMATCHED FAMILY MEMBERS OR MATCHED UNRELATED DONORS
Authors: CELA ME HOLLADAY MS ROONEY CM RICHARDSON S ALEXANDER B KRANCE RA BRENNER MK HESLOP HE
Citation: Me. Cela et al., GAMMA-DELTA T-LYMPHOCYTE REGENERATION AFTER T-LYMPHOCYTE-DEPLETED BONE-MARROW TRANSPLANTATION FROM MISMATCHED FAMILY MEMBERS OR MATCHED UNRELATED DONORS, Bone marrow transplantation, 17(2), 1996, pp. 243-247
HEPATIC ARTERIAL RESISTANCE INDEX - SPECIFIC INDICATOR OF LIVER DYSFUNCTION IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION
Authors: KAUFFMAN WM HESLOP HE GRONEMEYER SA CHEN G KRANCE RA
Citation: Wm. Kauffman et al., HEPATIC ARTERIAL RESISTANCE INDEX - SPECIFIC INDICATOR OF LIVER DYSFUNCTION IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION, Radiology, 201, 1996, pp. 998-998
PULMONARY COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION
Authors: WINERMURAM HT GURNEY JW BOZEMAN PM KRANCE RA
Citation: Ht. Winermuram et al., PULMONARY COMPLICATIONS AFTER BONE-MARROW TRANSPLANTATION, The Radiologic clinics of North America, 34(1), 1996, pp. 97
ACUTE MYELOID LEUKEMIAS (AML) OTHER THAN AML-M5 AND AML-M4 SUBTYPES CAN HAVE MLL GENE REARRANGEMENTS WITHOUT CYTOGENETIC EVIDENCE OF A CHROMOSOME 11Q23 ABNORMALITY
Authors: BEHM FG RAIMONDI SC RIBEIRO RC HEAD DR KRANCE RA
Citation: Fg. Behm et al., ACUTE MYELOID LEUKEMIAS (AML) OTHER THAN AML-M5 AND AML-M4 SUBTYPES CAN HAVE MLL GENE REARRANGEMENTS WITHOUT CYTOGENETIC EVIDENCE OF A CHROMOSOME 11Q23 ABNORMALITY, Laboratory investigation, 74(1), 1996, pp. 621-621
INDUCTION OF HEPATIC DRUG-METABOLISM DURING HIGH-DOSE PREPARATIVE CHEMOTHERAPY FOR BONE-MARROW (BMT)
Authors: RODMAN JH TONDA ME STRICKLIN LJ HESLOP HE KRANCE RA
Citation: Jh. Rodman et al., INDUCTION OF HEPATIC DRUG-METABOLISM DURING HIGH-DOSE PREPARATIVE CHEMOTHERAPY FOR BONE-MARROW (BMT), Clinical pharmacology and therapeutics, 59(2), 1996, pp. 36-36
IDENTICAL OUTCOMES OF ALLOGENEIC MATCHED SIBLING (MSD) AND UNRELATED DONOR (MUD) TRANSPLANTATION IN CHILDREN WITH LEUKEMIA
Authors: HONGENG S KRANCE RA BOWMAN LC SRIVASTAVA DK CUNNINGHAM JM HORWITZ EM BRENNER MK HESLOP HE
Citation: S. Hongeng et al., IDENTICAL OUTCOMES OF ALLOGENEIC MATCHED SIBLING (MSD) AND UNRELATED DONOR (MUD) TRANSPLANTATION IN CHILDREN WITH LEUKEMIA, Blood, 88(10), 1996, pp. 1926-1926
EFFICACY OF ADOPTIVELY TRANSFERRED VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL) FOR PROPHYLAXIS AND TREATMENT OF EBV LYMPHOMA
Authors: HESLOP HE SMITH CA NG C LOFTIN SK SIXBEY J KRANCE RA BRENNER MK ROONEY CM
Citation: He. Heslop et al., EFFICACY OF ADOPTIVELY TRANSFERRED VIRUS-SPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL) FOR PROPHYLAXIS AND TREATMENT OF EBV LYMPHOMA, Blood, 88(10), 1996, pp. 2713-2713
EPIPODOPHYLLOTOXIN-RELATED ACUTE MYELOID-LEUKEMIA - A STUDY OF 35 CASES
Authors: PUI CH RELLING MV RIVERA GK HANCOCK ML RAIMONDI SC HESLOP HE SANTANA VM RIBEIRO RC SANDLUND JT MAHMOUD HH EVANS WE CRIST WM KRANCE RA
Citation: Ch. Pui et al., EPIPODOPHYLLOTOXIN-RELATED ACUTE MYELOID-LEUKEMIA - A STUDY OF 35 CASES, Leukemia, 9(12), 1995, pp. 1990-1996
L-ASPARAGINASE MAY POTENTIATE THE LEUKEMOGENIC EFFECT OF THE EPIPODOPHYLLOTOXINS
Authors: PUI CH RELLING MV BEHM FG HANCOCK ML BOYETT JM RAIMONDI SC KRANCE RA MAHMOUD HH RIBEIRO RC SANDLUND JT HEAD DR EVANS WE CRIST WM RIVERA GK
Citation: Ch. Pui et al., L-ASPARAGINASE MAY POTENTIATE THE LEUKEMOGENIC EFFECT OF THE EPIPODOPHYLLOTOXINS, Leukemia, 9(10), 1995, pp. 1680-1684
GENETICALLY MARKED VIRUS-SPECIFIC CTLS TO CONTROL EBV-RELATEE LYMPHOPROLIFERATION
Authors: ROONEY CM SMITH CA NG CY LOFTIN SK LI C KRANCE RA BRENNER MK HESLOP H
Citation: Cm. Rooney et al., GENETICALLY MARKED VIRUS-SPECIFIC CTLS TO CONTROL EBV-RELATEE LYMPHOPROLIFERATION, Experimental hematology, 23(8), 1995, pp. 851-851
PORTAL VENOUS DOPPLER FINDINGS IN A BONE-MARROW TRANSPLANT PATIENT WITH CARDIAC-TAMPONADE
Authors: KAUFFMAN WM ZUCKERMAN SL HESLOP HE KRANCE RA
Citation: Wm. Kauffman et al., PORTAL VENOUS DOPPLER FINDINGS IN A BONE-MARROW TRANSPLANT PATIENT WITH CARDIAC-TAMPONADE, Journal of ultrasound in medicine, 14(11), 1995, pp. 877-879
RESPONSE OF STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE TO LYMPHOBLAST ANTIBODY CBL1
Authors: HESLOP HE BENAIM E BRENNER MK KRANCE RA STRICKLIN LM ROCHESTER RJ BILLING R
Citation: He. Heslop et al., RESPONSE OF STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE TO LYMPHOBLAST ANTIBODY CBL1, Lancet, 346(8978), 1995, pp. 805-806
USE OF GENE-MODIFIED VIRUS-SPECIFIC T-LYMPHOCYTES TO CONTROL EPSTEIN-BARR-VIRUS-RELATED LYMPHOPROLIFERATION
Authors: ROONEY CM SMITH CA NG CYC LOFTIN S LI CF KRANCE RA BRENNER MK HESLOP HE
Citation: Cm. Rooney et al., USE OF GENE-MODIFIED VIRUS-SPECIFIC T-LYMPHOCYTES TO CONTROL EPSTEIN-BARR-VIRUS-RELATED LYMPHOPROLIFERATION, Lancet, 345(8941), 1995, pp. 9-13
Risultati: 1-25 | 26-50 | 51-51